Cancer MoonShot 2020 has announced the formation of the Pediatrics Consortium focused on bringing the promise of combined immunotherapy as the next-generation standard of cancer care to children diagnosed with the disease. With leadership at Phoenix Children’s Hospital helping to initiate this consortium, all founding partners will seek to apply the most comprehensive cancer molecular diagnostic testing available—integrating whole genomic and proteomic analysis—and leverage proven and promising combination immunotherapies and clinical trials through the QUILT (QUantitative Integrative Lifelong Trial) Program within the Cancer MoonShot 2020 mission. Real-time data-sharing, enabled by the infrastructure provided by Cancer MoonShot 2020, will accelerate clinical learning and insight to all members participating in the consortium.
Founding Members and Member Institutions
- Stewart Goldman, MD, Ann & Robert H. Lurie Children’s Hospital of Chicago, Illinois
- Douglas K. Graham, MD, PhD, Children’s Healthcare of Atlanta, Georgia, Aflac Cancer & Blood Disorders Center
- Leonard S. Sender, MD, Children’s Hospital of Orange County, California
- Phillip B. Storm, MD, Children’s Hospital of Philadelphia, Pennsylvania
- Linda M. McAllister-Lucas, MD, PhD, Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pennsylvania
- Daniel S. Wechsler, MD, PhD, Department of Pediatrics of Duke University School of Medicine, North Carolina
- Giannoula Klement, MD, Floating Hospital for Children of Tufts Medical Center, Massachusetts
- Joshua D. Schiffman, MD, Huntsman Cancer Institute of the University of Utah and Intermountain Primary Children’s Hospital, Utah
- H. Stacy Nicholson, MD, Phoenix Children’s Hospital, Arizona
- Sam Milanovich, MD, Sanford Health, South Dakota
For more information on the Pediatrics Consortium, and Cancer MoonShot 2020, visit www.cancermoonshot2020.org. ■
